ALGORAE PHARMACEUTICALS LIMITED - Announcements

Market Cap $10.12M Add to my watchlist

Healthcare Biotechnology

Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an... Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an Australia-based pharmaceutical development company. The Company is focused on discovering and developing novel treatments for medical conditions with under met medical needs. Its programs include AlgoraeOS, Dementia and Parkinson’s. Its drug candidates include NTCELL for Parkinson’s disease and the AI-116 combination drug candidate for dementia. AlgoraeOS is a closed-loop platform, leveraging advanced computational tools to generate novel insights in-silico that are being developed to initiate or accelerate therapeutic programs. The AI-116 is a novel combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The NTCELL is an alginate coated capsule product containing clusters of neonatal porcine choroid plexus cells that are injected into the damaged site within the brain to target the treatment of Parkinson’s disease.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

1AI	SpringTree facility terminated by mutual consent	PRICE SENSITIVE	26/07/11	26.01KB	Share
1AI	LCT Enrols First Patients in DIABECELL Argentina Trial	PRICE SENSITIVE	27/06/11	29.12KB	Share
1AI	Resignation and Appointment of acting CEO	PRICE SENSITIVE	24/06/11	22.83KB	Share
1AI	SpringTree tranches paused until July	PRICE SENSITIVE	05/05/11	22.37KB	Share
1AI	LCT Approved for DIABECELL Clinical Trial in Argentina	PRICE SENSITIVE	03/05/11	31.87KB	Share
1AI	Appendix 4C - quarterly	PRICE SENSITIVE	20/04/11	63.35KB	Share
1AI	LCT and Otsuka of Japan Share Common DIABECELL Vision	PRICE SENSITIVE	12/04/11	191.89KB	Share
1AI	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	25/02/11	1.43MB	Share
1AI	LCTs encapsulating technology granted key Australian patent	PRICE SENSITIVE	24/02/11	24.45KB	Share
1AI	International foundations team up to fund LCT NZ Trial	PRICE SENSITIVE	16/02/11	295.13KB	Share
1AI	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/11	54.57KB	Share
1AI	LCT Completes First Closing on Funding	PRICE SENSITIVE	04/01/11	24.53KB	Share
1AI	LCT executes $5.75m funding agreement	PRICE SENSITIVE	31/12/10	232.32KB	Share
1AI	LCT Negotiating Funding	PRICE SENSITIVE	23/12/10	23.29KB	Share
1AI	LCT Approved to Further Expand DIABECELL NZ Trial	PRICE SENSITIVE	20/12/10	30.91KB	Share
1AI	LCT's DiabeCell Registered for Sale and Use in Russia	PRICE SENSITIVE	10/12/10	26.04KB	Share
1AI	Lifting of Trading Halt	PRICE SENSITIVE	18/11/10	18.62KB	Share
1AI	Trading Halt	PRICE SENSITIVE	18/11/10	40.61KB	Share
1AI	Promising Preclinical Results with NTCELL in Parkinsons	PRICE SENSITIVE	10/11/10	38.49KB	Share
1AI	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/10	57.16KB	Share
1AI	LCT reports sustained improvement from DIABECELL NZ Trial	PRICE SENSITIVE	27/10/10	35.19KB	Share
1AI	LCT Restructures Executive Team for Commercial Focus	PRICE SENSITIVE	23/09/10	35.6KB	Share
1AI	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	27/08/10	80.95KB	Share
1AI	LCT receives approval to expand DIABECELL NZ Trial	PRICE SENSITIVE	04/08/10	41.06KB	Share
1AI	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/10	82.8KB	Share
1AI	LCT reports consistent benefit in DIABECELL NZ Trial	PRICE SENSITIVE	13/07/10	41.06KB	Share
1AI	LCT Options underwritten	PRICE SENSITIVE	22/06/10	34.78KB	Share
1AI	Appendix 4C	PRICE SENSITIVE	29/04/10	212.4KB	Share
1AI	LCT receives grant from Juvenile Diabetes Research Foundn	PRICE SENSITIVE	27/04/10	42.33KB	Share
1AI	Report from LCTs Russian Phase I / IIa Diabetes Trial	PRICE SENSITIVE	07/04/10	51.86KB	Share
1AI	LCT Phase II Diabetes Trial Success - Approval to Progress	PRICE SENSITIVE	30/03/10	41.53KB	Share
1AI	Response to ASX Price Query	PRICE SENSITIVE	17/03/10	60.55KB	Share
1AI	Russia registers LCT encapsulation delivery device	PRICE SENSITIVE	10/03/10	21.37KB	Share
1AI	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/10	275.75KB	Share
1AI	LCT Awarded NZ$4.04 Million New Zealand Government Grant	PRICE SENSITIVE	12/02/10	32.08KB	Share
1AI	LCT Receives 10% of US Based Wound Healing Company	PRICE SENSITIVE	09/02/10	29.33KB	Share
1AI	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/10	83.17KB	Share
1AI	LCT alerted to issue of fake share certificates	PRICE SENSITIVE	27/01/10	27.81KB	Share
1AI	LCT Granted European Patent for NTCELL	PRICE SENSITIVE	20/01/10	63.4KB	Share
1AI	LCT signs new research collaboration and option agreement	PRICE SENSITIVE	21/12/09	29.21KB	Share
1AI	LCT considers Australian trials following lifting of ban	PRICE SENSITIVE	10/12/09	30.87KB	Share
1AI	LCT Clinical Trial Release	PRICE SENSITIVE	04/12/09	65.44KB	Share
1AI	LCT Announces Share Purchase Plan	PRICE SENSITIVE	16/11/09	30.29KB	Share
1AI	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/09	81.53KB	Share
1AI	LCT Updates Progress with Diabetes Clinical Trial	PRICE SENSITIVE	27/10/09	46.07KB	Share
1AI	LCT Reports Successful First Implant Of DIABECELL in NZ	PRICE SENSITIVE	07/10/09	61.39KB	Share
1AI	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	31/08/09	60.14KB	Share
1AI	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/09	82.45KB	Share
1AI	Share Placement	PRICE SENSITIVE	30/07/09	30.82KB	Share
1AI	Reinstatement to Official Quotation	PRICE SENSITIVE	30/07/09	8.61KB	Share
1AI	Suspension from Official Quotation	PRICE SENSITIVE	29/07/09	18.84KB	Share
1AI	Trading Halt	PRICE SENSITIVE	27/07/09	20.4KB	Share
1AI	LCT NZ Clinical Trials commence	PRICE SENSITIVE	22/07/09	62.19KB	Share
1AI	LCT Diabetes Clinical Trial authorized by NZ Government	PRICE SENSITIVE	24/06/09	64.2KB	Share
1AI	Revised Conditions for LCT NZ Clinical Trial	PRICE SENSITIVE	19/06/09	112.42KB	Share
1AI	Living Cell Technologies - Capital Raising Cancelled	PRICE SENSITIVE	22/05/09	26.93KB	Share
1AI	Trading Halt	PRICE SENSITIVE	22/05/09	18.55KB	Share
1AI	LCT Clinical Trial 2 Patients achieve insulin independence	PRICE SENSITIVE	05/05/09	68.18KB	Share
1AI	Appendix 4C	PRICE SENSITIVE	30/04/09	80.3KB	Share
1AI	LCT's New Zealand Pigs Free of Viruses	PRICE SENSITIVE	27/04/09	27.13KB	Share
1AI	New Zealand Clinical Trial	PRICE SENSITIVE	17/04/09	55.77KB	Share
1AI	Clinical Update	PRICE SENSITIVE	06/04/09	27.6KB	Share
1AI	Appendix 4D - Half Year Accounts	PRICE SENSITIVE	27/02/09	638.34KB	Share
1AI	LCT reports substained benefit with DIABECELL	PRICE SENSITIVE	11/02/09	59.15KB	Share
1AI	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/09	102.96KB	Share
1AI	Cash conservation and change of CEO	PRICE SENSITIVE	23/12/08	24.62KB	Share
1AI	LCT's NeurotrophinCell effective in Parkinson's disease	PRICE SENSITIVE	11/12/08	30.74KB	Share

1AISpringTree facility terminated by mutual consent
26/07/11	PRICE SENSITIVE	26.01KB	Share
1AILCT Enrols First Patients in DIABECELL Argentina Trial
27/06/11	PRICE SENSITIVE	29.12KB	Share
1AIResignation and Appointment of acting CEO
24/06/11	PRICE SENSITIVE	22.83KB	Share
1AISpringTree tranches paused until July
05/05/11	PRICE SENSITIVE	22.37KB	Share
1AILCT Approved for DIABECELL Clinical Trial in Argentina
03/05/11	PRICE SENSITIVE	31.87KB	Share
1AIAppendix 4C - quarterly
20/04/11	PRICE SENSITIVE	63.35KB	Share
1AILCT and Otsuka of Japan Share Common DIABECELL Vision
12/04/11	PRICE SENSITIVE	191.89KB	Share
1AIAppendix 4D and Half Year Accounts
25/02/11	PRICE SENSITIVE	1.43MB	Share
1AILCTs encapsulating technology granted key Australian patent
24/02/11	PRICE SENSITIVE	24.45KB	Share
1AIInternational foundations team up to fund LCT NZ Trial
16/02/11	PRICE SENSITIVE	295.13KB	Share
1AIAppendix 4C - quarterly
28/01/11	PRICE SENSITIVE	54.57KB	Share
1AILCT Completes First Closing on Funding
04/01/11	PRICE SENSITIVE	24.53KB	Share
1AILCT executes $5.75m funding agreement
31/12/10	PRICE SENSITIVE	232.32KB	Share
1AILCT Negotiating Funding
23/12/10	PRICE SENSITIVE	23.29KB	Share
1AILCT Approved to Further Expand DIABECELL NZ Trial
20/12/10	PRICE SENSITIVE	30.91KB	Share
1AILCT's DiabeCell Registered for Sale and Use in Russia
10/12/10	PRICE SENSITIVE	26.04KB	Share
1AILifting of Trading Halt
18/11/10	PRICE SENSITIVE	18.62KB	Share
1AITrading Halt
18/11/10	PRICE SENSITIVE	40.61KB	Share
1AIPromising Preclinical Results with NTCELL in Parkinsons
10/11/10	PRICE SENSITIVE	38.49KB	Share
1AIAppendix 4C - quarterly
29/10/10	PRICE SENSITIVE	57.16KB	Share
1AILCT reports sustained improvement from DIABECELL NZ Trial
27/10/10	PRICE SENSITIVE	35.19KB	Share
1AILCT Restructures Executive Team for Commercial Focus
23/09/10	PRICE SENSITIVE	35.6KB	Share
1AIAppendix 4E - Preliminary Final Report
27/08/10	PRICE SENSITIVE	80.95KB	Share
1AILCT receives approval to expand DIABECELL NZ Trial
04/08/10	PRICE SENSITIVE	41.06KB	Share
1AIAppendix 4C - quarterly
30/07/10	PRICE SENSITIVE	82.8KB	Share
1AILCT reports consistent benefit in DIABECELL NZ Trial
13/07/10	PRICE SENSITIVE	41.06KB	Share
1AILCT Options underwritten
22/06/10	PRICE SENSITIVE	34.78KB	Share
1AIAppendix 4C
29/04/10	PRICE SENSITIVE	212.4KB	Share
1AILCT receives grant from Juvenile Diabetes Research Foundn
27/04/10	PRICE SENSITIVE	42.33KB	Share
1AIReport from LCTs Russian Phase I / IIa Diabetes Trial
07/04/10	PRICE SENSITIVE	51.86KB	Share
1AILCT Phase II Diabetes Trial Success - Approval to Progress
30/03/10	PRICE SENSITIVE	41.53KB	Share
1AIResponse to ASX Price Query
17/03/10	PRICE SENSITIVE	60.55KB	Share
1AIRussia registers LCT encapsulation delivery device
10/03/10	PRICE SENSITIVE	21.37KB	Share
1AIHalf Yearly Report and Accounts
25/02/10	PRICE SENSITIVE	275.75KB	Share
1AILCT Awarded NZ$4.04 Million New Zealand Government Grant
12/02/10	PRICE SENSITIVE	32.08KB	Share
1AILCT Receives 10% of US Based Wound Healing Company
09/02/10	PRICE SENSITIVE	29.33KB	Share
1AIAppendix 4C - quarterly
29/01/10	PRICE SENSITIVE	83.17KB	Share
1AILCT alerted to issue of fake share certificates
27/01/10	PRICE SENSITIVE	27.81KB	Share
1AILCT Granted European Patent for NTCELL
20/01/10	PRICE SENSITIVE	63.4KB	Share
1AILCT signs new research collaboration and option agreement
21/12/09	PRICE SENSITIVE	29.21KB	Share
1AILCT considers Australian trials following lifting of ban
10/12/09	PRICE SENSITIVE	30.87KB	Share
1AILCT Clinical Trial Release
04/12/09	PRICE SENSITIVE	65.44KB	Share
1AILCT Announces Share Purchase Plan
16/11/09	PRICE SENSITIVE	30.29KB	Share
1AIAppendix 4C - quarterly
30/10/09	PRICE SENSITIVE	81.53KB	Share
1AILCT Updates Progress with Diabetes Clinical Trial
27/10/09	PRICE SENSITIVE	46.07KB	Share
1AILCT Reports Successful First Implant Of DIABECELL in NZ
07/10/09	PRICE SENSITIVE	61.39KB	Share
1AIAppendix 4E - Preliminary Final Report
31/08/09	PRICE SENSITIVE	60.14KB	Share
1AIAppendix 4C - quarterly
30/07/09	PRICE SENSITIVE	82.45KB	Share
1AIShare Placement
30/07/09	PRICE SENSITIVE	30.82KB	Share
1AIReinstatement to Official Quotation
30/07/09	PRICE SENSITIVE	8.61KB	Share
1AISuspension from Official Quotation
29/07/09	PRICE SENSITIVE	18.84KB	Share
1AITrading Halt
27/07/09	PRICE SENSITIVE	20.4KB	Share
1AILCT NZ Clinical Trials commence
22/07/09	PRICE SENSITIVE	62.19KB	Share
1AILCT Diabetes Clinical Trial authorized by NZ Government
24/06/09	PRICE SENSITIVE	64.2KB	Share
1AIRevised Conditions for LCT NZ Clinical Trial
19/06/09	PRICE SENSITIVE	112.42KB	Share
1AILiving Cell Technologies - Capital Raising Cancelled
22/05/09	PRICE SENSITIVE	26.93KB	Share
1AITrading Halt
22/05/09	PRICE SENSITIVE	18.55KB	Share
1AILCT Clinical Trial 2 Patients achieve insulin independence
05/05/09	PRICE SENSITIVE	68.18KB	Share
1AIAppendix 4C
30/04/09	PRICE SENSITIVE	80.3KB	Share
1AILCT's New Zealand Pigs Free of Viruses
27/04/09	PRICE SENSITIVE	27.13KB	Share
1AINew Zealand Clinical Trial
17/04/09	PRICE SENSITIVE	55.77KB	Share
1AIClinical Update
06/04/09	PRICE SENSITIVE	27.6KB	Share
1AIAppendix 4D - Half Year Accounts
27/02/09	PRICE SENSITIVE	638.34KB	Share
1AILCT reports substained benefit with DIABECELL
11/02/09	PRICE SENSITIVE	59.15KB	Share
1AIAppendix 4C - quarterly
30/01/09	PRICE SENSITIVE	102.96KB	Share
1AICash conservation and change of CEO
23/12/08	PRICE SENSITIVE	24.62KB	Share
1AILCT's NeurotrophinCell effective in Parkinson's disease
11/12/08	PRICE SENSITIVE	30.74KB	Share

REFRESH

First 2

(20min delay)
Last 0.6¢		Change -0.001(14.3%)		Mkt cap ! $10.12M

Open	High	Low	Value	Volume
0.6¢	0.6¢	0.6¢	$477	79.44K

Buyers (Bids)

No.	Vol.	Price($)
16	6813716	0.5¢

Sellers (Offers)

Price($)	Vol.	No.
0.6¢	20556	1

View Market Depth

No.	Vol.	Price($)
16	6813716	0.005
5	3095009	0.004
3	3800000	0.003
2	1050000	0.002
1	500000	0.001

Price($)	Vol.	No.
0.007	2107207	9
0.008	883402	6
0.009	869315	6
0.010	2767476	4
0.011	90000	1

Last trade - 15.34pm 01/11/2024 (20 minute delay)

1AI (ASX) Chart

ALGORAE PHARMACEUTICALS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available